Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7237 results

Sort By:

Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant

Study ID: NCT02333162
Start Date: 2014-12-05
End Date: 2028-12-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

Fludarabine Phosphate

Melphalan

Intensity-Modulated Radiation Therapy

Total Marrow Irradiation

Allogeneic Hematopoietic Stem Cell Transplantation

Peripheral Blood Stem Cell Transplantation

Allogeneic Bone Marrow Transplantation

Tacrolimus

Mycophenolate Mofetil

Laboratory Biomarker Analysis

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

Accelerated Pulmonary Rehabilitation in the Preoperative Period

Study ID: NCT06432972
Start Date: 2024-01-02
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Pulmonary Rehab

Sponsor

University of Vermont

Source: clinicaltrials.gov

Share:
Add to list

Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC

Study ID: NCT06855212
Start Date: 2025-02-26
End Date: 2028-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

21

Intervention / Treatment

Cemiplimab

Cetuximab

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Source: clinicaltrials.gov

Share:
Add to list

Iberdomide Alone or in Combination with Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma

Study ID: NCT04776395
Start Date: 2021-08-01
End Date: 2025-10-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

68

Intervention / Treatment

Dexamethasone

Iberdomide Hydrochloride

Quality-of-Life Assessment

Sponsor

Emory University

Source: clinicaltrials.gov

Share:
Add to list

Clinical Nurse Specialist Led Early Palliative Survivorship Care for Patients With Advanced Cancer

Study ID: NCT05947695
Start Date: 2023-03-02
End Date: 2029-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Palliative and Survivorship Care Model

Sponsor

Good Samaritan Hospital Medical Center, New York

Source: clinicaltrials.gov

Share:
Add to list

Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

Study ID: NCT06130995
Start Date: 2024-12-26
End Date: 2030-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

46

Intervention / Treatment

Relugolix and Enzalutamide

Sponsor

University of Oklahoma

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG

Study ID: NCT05555550
Start Date: 2025-03-03
End Date: 2026-09
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

30

Intervention / Treatment

18F-Fluciclovine

Sponsor

Children's Hospital of Philadelphia

Source: clinicaltrials.gov

Share:
Add to list

Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma

Study ID: NCT06203912
Start Date: 2024-03-05
End Date: 2025-08-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

Biospecimen Collection

Bone Marrow Aspiration and Biopsy

Cyclophosphamide

Dexamethasone

Echocardiography

Isatuximab

Administration questionnaire

Universal Donor Expanded TGF-beta-imprinted NK Cells

Sponsor

Elvira Umyarova

Source: clinicaltrials.gov

Share:
Add to list

MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer

Study ID: NCT06677112
Start Date: 2025-03-17
End Date: 2030-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

625

Intervention / Treatment

Selective surgical staging

REFLEX

Sponsor

Rachel Miller

Source: clinicaltrials.gov

Share:
Add to list

Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)

Study ID: NCT05043012
Start Date: 2022-07-18
End Date: 2027-02-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

258

Intervention / Treatment

flexible AIR coil

endorectal coi

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list